DSGN
Design Therapeutics Inc

387
Mkt Cap
$594.7M
Volume
115,673.00
52W High
$11.14
52W Low
$2.60
PE Ratio
-8.80
DSGN Fundamentals
Price
$10.44
Prev Close
$10.68
Open
$10.53
50D MA
$9.89
Beta
1.60
Avg. Volume
310,829.80
EPS (Annual)
-$0.8763
P/B
2.98
Rev/Employee
$0.00
$106.00
Loading...
Loading...
News
all
press releases
Design Therapeutics Highlights GeneTAC Pipeline, FA Data Timeline and DM1 Dosing Plans at Oppenheimer Conference
Design Therapeutics (NASDAQ:DSGN) outlined progress across three clinical-stage programs and discussed upcoming catalysts during an Oppenheimer healthcare conference presentation led by CEO Pratik...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Hits New 1-Year High - What's Next?
Design Therapeutics (NASDAQ:DSGN) Reaches New 12-Month High - Here's Why...
MarketBeat·4d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Sees Strong Trading Volume - Should You Buy?
Design Therapeutics (NASDAQ:DSGN) Sees Large Volume Increase - Should You Buy...
MarketBeat·10d ago
News Placeholder
Short Interest in Design Therapeutics, Inc. (NASDAQ:DSGN) Drops By 14.0%
Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) was the recipient of a large decline in short interest in the month of January. As of January 30th, there was short interest totaling...
MarketBeat·12d ago
News Placeholder
Design Therapeutics, Inc. (NASDAQ:DSGN) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five ratings firms that are presently covering the firm, MarketBeat Ratings reports...
MarketBeat·12d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded Design Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·15d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Shares Gap Up - Still a Buy?
Design Therapeutics (NASDAQ:DSGN) Shares Gap Up - Still a Buy...
MarketBeat·30d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Sees Large Volume Increase - Time to Buy?
Design Therapeutics (NASDAQ:DSGN) Sees Large Volume Increase - Time to Buy...
MarketBeat·1mo ago
News Placeholder
Design Therapeutics, Inc. (NASDAQ:DSGN) Given Consensus Rating of "Moderate Buy" by Brokerages
Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the five analysts that are covering the company, MarketBeat.com reports. One...
MarketBeat·1mo ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Sets New 52-Week High - Here's What Happened
Design Therapeutics (NASDAQ:DSGN) Sets New 52-Week High - Time to Buy...
MarketBeat·1mo ago
<
1
2
...
>

Latest DSGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.